Axogen (AXGN) Cash from Investing Activities (2010 - 2026)
Axogen (AXGN) recorded quarterly Cash from Investing Activities of -$16.0 million in Q1 2026, down 494.95% quarter-over-quarter from $4.0 million in Q4 2025, and down 1292.23% on a YoY basis from $1.3 million in Q1 2025.
Axogen (AXGN) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Axogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$16.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 1292.23% year-over-year to -$16.0 million; the TTM figure through Mar 2026 stood at -$22.6 million (down 296.36% YoY), while the FY2025 annual figure was -$5.3 million, up 48.36% from the prior year.
- Cash from Investing Activities was -$16.0 million for Q1 2026 at Axogen, down from $4.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $14.3 million in Q2 2023 to a low of -$16.0 million in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$913235.3 across 5 years, with a median of -$813000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities jumped 597.17% in 2025, then sank 1292.23% in 2026.
- A 5-year view of Cash from Investing Activities shows it stood at -$1.2 million in 2022, then jumped by 77.09% to -$277000.0 in 2023, then sank by 193.5% to -$813000.0 in 2024, then surged by 597.17% to $4.0 million in 2025, then tumbled by 494.95% to -$16.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$16.0 million (Q1 2026), $4.0 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Axogen | 2.22 Bn | 2.12 Bn | 46.19 Mn | -15.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.96 Mn |
| Mar 31, 2026 | -15.96 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Jun 30, 2025 | -6.95 Mn |
| Jun 30, 2025 | -6.95 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | -813,000.00 |
| Dec 31, 2024 | -813,000.00 |
| Sep 30, 2024 | -5.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Dec 31, 2023 | -277,000.00 |
| Dec 31, 2023 | -277,000.00 |